Linked Life Data

18930555

Source:http://linkedlifedata.com/resource/pubmed/id/18930555

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2008-12-1
pubmed:abstractText
To report the association between 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitors (statins) and diplopia, blepharoptosis (ptosis), and ophthalmoplegia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1549-4713
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2282-5
pubmed:meshHeading
pubmed-meshheading:18930555-Adult, pubmed-meshheading:18930555-Adverse Drug Reaction Reporting Systems, pubmed-meshheading:18930555-Aged, pubmed-meshheading:18930555-Aged, 80 and over, pubmed-meshheading:18930555-Blepharoptosis, pubmed-meshheading:18930555-Cardiovascular Diseases, pubmed-meshheading:18930555-Databases, Factual, pubmed-meshheading:18930555-Diplopia, pubmed-meshheading:18930555-Female, pubmed-meshheading:18930555-Humans, pubmed-meshheading:18930555-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:18930555-Male, pubmed-meshheading:18930555-Middle Aged, pubmed-meshheading:18930555-Ophthalmoplegia, pubmed-meshheading:18930555-Time Factors, pubmed-meshheading:18930555-United States, pubmed-meshheading:18930555-United States Food and Drug Administration, pubmed-meshheading:18930555-World Health Organization
pubmed:year
2008
pubmed:articleTitle
Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
pubmed:affiliation
Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon 97239-4197, USA. eyedrug@ohsu.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't